IM Cannabis Corp

IM Cannabis Corp. engages in the production and sale of medical cannabis products. It offers dry flower products and cannabis oil products under the IMC brand. The company was founded on March 7, 1980 and is headquartered in Glil Yam, Israel.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

TORONTO, GLIL YAM, Israel and KELOWNA, BC., April 4, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, and Avant Brands Inc. (TSX: AVNT) (OTCQX: AVTBF) (FRA: 1BU0) ("Avant") a leading producer of innovative cannabis products, jointly announce the signing of an international trademark licensing agreement (the "Licensing Agreement") granting Adjupharm GmbH, IMC's German subsidiary ("Adjupharm" or "IMC Germany", as applicable), the exclusive right to launch the BLK MKT™ brand in the German medical cannabis market.

Avant and IMC Execute BLK MKT™ Trademark Licensing Agreement for the German Medical Cannabis Market

KELOWNA, BC, TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / April 4, 2024 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products and IM Cannabis Corp. (CSE:IMCC)(NASDAQ:IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, are pleased to announce the signing of an International Trademark Licensing Agreement (the "Licensing Agreement") granting IMC's German subsidiary, Adjupharm GmbH ("Adjupharm"), the exclusive right to launch Avant's flagship brand, BLK MKT™ brand in the German cannabis market. The Licensing Agreement constitutes a significant expansion of the relationship between the two industry-leading cannabis companies.

Avant Brands Bolsters International Growth in German Cannabis Market Through Partnership with IMC

Tilray Brands

Village Farms International

Marijuana stock investors are keeping their focus on the future. But why some may ask? With the cannabis sector being so volatile several things will need to take place for better trading. All of this will need to happen in the near to far future for stronger confidence regarding cannabis investing. This year we have seen a continuation of growth in the form of revenue and an increase in demand for more cannabis products.

3 Marijuana Stocks To Watch Today In April

With the implementation of the anticipated medical cannabis regulatory reform, the Israeli ministry of health removed many of the heavy regulations in the sector, making medical cannabis more accessible to new patients. TORONTO and GLIL YAM, Israel , April 1, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, welcomes the implementation of the medical cannabis regulatory reform in Israel on April 1 st.

IMC applauds the April 1st implementation of the new Israeli cannabis regulation, facilitating access for many new patients

IM Cannabis Corp. (IMCC) Q4 2023 Earnings Call Transcript

TORONTO and GLIL YAM, Israel, March 28, 2024 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial and operational results for the year ended December 31, 2023, the highlights of which are included in this news release. All figures are reported in Canadian dollars.

IM Cannabis Reports 2023 Financial Results

By rescheduling medical cannabis, from a narcotic to a regular prescription, the German medical cannabis market is expected to deliver strong growth, providing IMC Germany with a unique opportunity to further accelerate growth in 2024 after delivering 180% growth in 2023 TORONTO and GLIL YAM, Israel , March 25, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is welcoming the German government's final approval legalizing cannabis last Friday, as well as the landmark medical cannabis act that has the potential to facilitate access for many new patients as of April 1 st. The regulatory rescheduling of cannabis along with the expected market growth, provides IMC with a unique growth opportunity.

IMC Expects Accelerated Growth in Germany from the Country's Groundbreaking Cannabis Legalization

TORONTO and GLIL YAM, Israel , March 20, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company", "IMCannabis", or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the fourth quarter and full year 2023 ended December 31, 2023, on Thursday, March 28, 2024 before the market opens. The Company will host a zoom web conference on the same day at 9:00a.m.

IM Cannabis to Report Fourth Quarter and Full Year 2023 Financial Results on Thursday, March 28 at 9:00am ET

Leafly Holdings

WM Technology

The cannabis industry over the last several years has seen tremendous growth. Many companies through ups and downs are seeing stronger sales. Recently companies have been reporting their earnings and the profits are high for most. This success has helped drive some much-needed moments into the stock market for certain marijuana stocks. Often when the news is impactful enough it can help how some cannabis stocks perform.

Close Out The Week With These Marijuana Stocks

Clever Leaves Holdings Inc

As the cannabis industry continues to flourish in the United States, investors are keenly watching the market for top-performing marijuana stocks. With the industry projected to reach a staggering $30 billion by 2025, the allure of double-digit gains before March is strong. Recent updates on federal legalization efforts have further invigorated the market. These developments promise to expand the industry's legal framework, potentially unlocking vast untapped markets. Investors are advised to employ technical analysis and proper risk management strategies. These tools are crucial for navigating the volatile cannabis sector. They help identify promising entry and exit points, maximizing returns while minimizing risks.

High Growth: Top Pot Stocks Making Moves into March 2024

TORONTO and GLIL YAM, Israel , Jan. 31, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, announced today that it has received a 180 calendar day extension, until July 29, 2024, from the Nasdaq Stock Market ("Nasdaq"), to regain compliance with Nasdaq Marketplace Rule 5550(a)(2) (the "Bid Price Rule"). The Bid Price Rule stipulates that the bid price of the Company's common stock must close at $1.00 per share or more for a minimum of 10 consecutive business days.

IM Cannabis Receives 180 Calendar Day Extension from the Nasdaq Stock Market to Regain Compliance with Bid Price Rule

TORONTO and GLIL YAM, Israel , Jan. 12, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is announcing that the final sixth payment of the Oranim Pharmacy Acquisition and the reconciliation between the parties regarding the remaining transaction payments are being rescheduled to April 15, 2024. Through the transaction, completed on March 28, 2022, IMC Holdings Ltd.

IMC Reschedules the Final Payment of the Oranim Pharmacy Acquisition

TORONTO and GLIL YAM, Israel , Jan. 2, 2024 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is announcing that the construction proceedings against Focus Medical Herbs Ltd. ("Focus Medical"), were concluded on December 28, 2023.

IMC Announces the Conclusion of the Planning and Construction Legal Proceedings

TORONTO and GLIL YAM, Israel , Dec. 8, 2023 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany, is announcing a 3-month delay of the anticipated medical cannabis reform announced by the Israeli ministry of health on August 7, 2023 (the "Reform"). Due to the Israel-Hamas war, the anticipated implementation of the medical cannabis regulatory reform, originally scheduled for December 29, 2023, has been postponed by three months.

New Israeli cannabis regulation, facilitating access for many new patients, scheduled for December 29, 2023, has been postponed by three months; Israeli Ministry of Health published a new report showing a surge in new medical cannabis patients in November

Even with the amount of progress the cannabis industry has seen investing in legal cannabis comes with big risks. As many know cannabis is now legal in more than 30 states in the US. This emerging industry has consistently generated over a billion in revenue. Not to mention it has employed many people who are looking for work. There seem to be more positives than negatives regarding legal cannabis so why is investing so risky?

The Best Marijuana Stocks For You To Watch Today

High Tide

This upcoming year marijuana stock investors await to see what will occur. There is a split between optimism and increased fears of what will go wrong. Many are still stuck in disbelief that there has been no advancement of any type of federal reform. You would think with over a billion dollars quarterly per legal state that federal reform would be a no-brainer. But it is not that simple however every time positive news on the matter is released the market begins to recover.

These Marijuana Stocks Could Make Your Monday Watchlist

TORONTO and GLIL YAM, Israel , Nov. 27, 2023 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany announces that a complaint was in the Ontario Superior Court of Justice in Canada by Michael Wiener, 35 Oak Holdings Ltd. and MW Investments Ltd.

IM Cannabis Announces Receipt of Court Action

Although cannabis is still federally illegal more than half of the USA has established a legal market. Now with no federal reform in place, this has led to more concern about investing in legal cannabis. This has also been the cause of the increase in volatile trading for most marijuana stocks. Nevertheless, there is an ongoing battle to get federal reform passed. Many feel that rescheduling cannabis will be the biggest challenge for the industry to reach its full potential.

Marijuana Stocks To Watch That Are Impacted By Cannabis Reform

IM Cannabis Corp. (NASDAQ:IMCC ) Q3 2023 Results Conference Call November 13, 2023 9:00 AM ET Company Participants Anna Taranko - Director of Investor and Public Relations Oren Shuster - Chief Executive Officer Itay Vago - Chief Financial Officer Conference Call Participants Scott Fortune - ROTH MKM Aaron Grey - Alliance Global Operator Good morning. And welcome to IM Cannabis' Third Quarter 2023 Earnings Conference Call.

IM Cannabis Corp. (IMCC) Q3 2023 Earnings Call Transcript

IMC remains singularly focused on accelerating its path to profitability through active cost management and margin improvement while maintaining sales. TORONTO, and GLIL YAM, Israel , Nov. 13, 2023 /PRNewswire/ -- IM Cannabis Corp. (the "Company" or "IMC") (NASDAQ: IMCC) (CSE: IMCC), an international medical cannabis company, announced its financial results today for the third quarter ended September 30, 2023.

IM Cannabis Reports Third Quarter 2023 Financial Results

Greenlane Holdings

In the ever-evolving landscape of the cannabis market, ancillary marijuana stocks have emerged as hidden gems, often overshadowed by the spotlight on direct cultivators. In general, these ancillary companies, supplying various accessories and services to the cannabis industry, play a crucial role in its expansion. From cutting-edge vaporizers to innovative packaging solutions, these stocks offer investors a unique entry point into the cannabis boom.

Budding Profits: Top Ancillary Cannabis Stocks to Watch This November

TORONTO and GLIL YAM, Israel , Nov. 8, 2023 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company," "IMCannabis," or "IMC"), a leading medical cannabis company with operations in Israel and Germany, will report operational and financial results for the second quarter ended September 30, 2023, on Monday, November 13, 2023 before the market opens. The Company will host a zoom web conference on the same day at 9:00 a.m.

IM Cannabis to Report Third Quarter 2023 Financial Results on Monday, November 13 at 9:00am ET

Marijuana stock investors are keeping watch for the next investment opportunity. For some time there has been a rise in market volatility in the cannabis sector. This has been both positive and negative for shareholders and investors. The upside to volatility is that when there is a pullback it gives people a chance to find top marijuana stocks to buy. But it's the price point and how low shares typically cost. Now the upside is having a volatile rise in trading and this is when people would take profits.

Investing In Marijuana Stocks 2024

With exponential growth prospects, the cannabis sector and top marijuana stocks are booming globally. Cannabis is growing into a huge economic force as more nations legalize it for medical and recreational use, and investors are eager to tap into this emerging market. Trading ancillary and international cannabis stocks, now valued under $2, is one investment strategy that investors find particularly alluring. In general, this offers traders a low-cost starting point and takes advantage of the cannabis industry's unquestionable potential. Industry projections predict that the global cannabis market will expand at a compound annual growth rate of 18.1% to reach $73.6 billion by 2027. In addition, this growth is primarily due to the increasing acceptance of cannabis for medicinal use, the decriminalization of recreational consumption, and the ongoing market expansion into new territories.

Top Marijuana Stocks Under $2 for This Week's Trading

TORONTO and GLIL YAM, Israel , Oct. 13, 2023 /PRNewswire/ -- IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the "Company" or "IMC"), a leading medical cannabis company with operations in Israel and Germany releases message from Chief Executive Officer about the Israel-Hamas War and announces the Company, through its wholly-owned subsidiaries, IMC Holdings Ltd. ("IMC HoldCo") and Rosen High Way Ltd.

News for IM Cannabis Corp Stock (IMCC)